According to Harmony Biosciences's latest financial reports the company's current revenue (TTM) is $0.58 B. In 2022 the company made a revenue of $0.43 B an increase over the years 2021 revenue that were of $0.30 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.58 B | 32.93% |
2022 | $0.43 B | 43.35% |
2021 | $0.30 B | 91.21% |
2020 | $0.15 B | 2564.59% |
2019 | $5.99 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.86 B | 48.36% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $0.22 M | -99.96% | ๐บ๐ธ USA |